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Abstracts / Urological Science 26 (2015) S50eS81S70Purpose: In upper urinary tract (UUT), squamous cell carcinoma (SCC) and
urothelial carcinoma (UC) are two different disease in its etiology, inci-
dence and prognosis. Due to paucity of the study in SCC, we treat it just as
UC. However, we believe the therapeutic and following protocols for the
two diseases are different. In this study, we compare the bladder recur-
rence rate in these two malignancies.
Materials and Methods: From January 2000 to December 2007, 327 pa-
tients were diagnosed as upper urinary tract malignancy. Their clinical and
pathological characteristics were retrospectively reviewed. There were
294 pure UC (90.0%), 24 UCwith squamous differentiation (SqD) (7.3%) and
9 pure SCC (2.7%) patient. These patients all received RNU initially. Kaplan-
Meier method was used to estimate bladder recurrence free survival (RFS).
The recurrence curve is compared by log rank test. The statistical signiﬁ-
cance was set as p&0.05.
Results: The 5-year RFSs of bladder were 67.9%, 70.4 and 100% in UC, UC
with SqD and SCC groups respectively. Pairwise comparisonwas done., and
here was no signiﬁcant difference in bladder RFS between two groups. The
p-value of log-rank test comparing UC and SCC is 0.061. Although not
statistically signiﬁcant, there was a trend that patients with UUT-SCC had
less bladder recurrence after initially operative management.
Conclusion: There was a statistical trend that patients with UUT-SCC had
less bladder recurrence after initially operative management. It did not
reach signiﬁcance because of the small number of patients with SCC.
NDP079:
ANDROGEN-DEPENDENT PROSTATE CANCER CELLS INTO NON-
ANDROGEN DEPENDENT PROCESS THE ROLE OF MICRORNA
Jui-Ming Liu 1, Ren-Jun Hsu 2. 1Division of Urology, Department of Surgery,
Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan,
Taiwan; 2Department of Pathology and Graduate Institute of Pathology and
Parasitology Tri-Service General Hospital, National Defense Medical Center,
Taipei, Taiwan
Purpose: To compare the observed androgen-dependent prostate cancer
cells (LNCaP), transformed into a differential expression of androgen-in-
dependent prostate cancer cells (LNCaP -androgen independent) process
microRNA explore highmicroRNA expression differences in the conversion
process regulatory mechanisms may play its target genes.
Materials andMethods: LNCaP, anti-androgen drugs (high expression and
low expression for 3 months LNCaP and LNCaP -androgen independent
transformed into microRNA expression between cells, choose large dif-
ferences in the use of Agilent to validate, and bioinformatics analysis,
looking for differences in the expression of microRNA target gene. Lucif-
erase reporter assay to demonstrate the use of the target gene does. This
will take advantage of siRNA way to suppress or to increase the perfor-
mance of high performance differences of microRNA, microRNA to conﬁrm
the high performance difference does affect the formation of androgen-
independent prostate cancer cells
Results: Under the gene chip can get more than 100 have differences in
microRNA, but we only pick the difference more than 10 times higher
than the microRNA analysis to identify prostate cancer cells are most
likely to affect the transition from androgen-dependent a non-androgen
dependent microRNA. We found miR-221 is the highest performance
microRNA.
Conclusion: The miR-221 is one of the highest performance difference
does affect the formation of androgen-independent prostate cancer cells.
NDP080:
ADULT WILMS' TUMOR: SINGLE INSTITUTION EXPERIENCE AND
REVIEW OF LITERATURES
Yu-Hua Shau 1,2, Sheng-Tang Wu 1, Shou-Hung Tang 1, Tai-Lung Cha 1, Chih-
Wei Tsao 1, En Meng 1, Dah-Shyong Yu 1, Guang-Huan Sun 1, Chien-Chang
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Purpose: Wilms' tumor (nephroblastoma) is the most common solid pri-
mary renal malignancy in children but extremely rare in adult population.We present single institution experience of adult Wilms' tumor in order to
assess the clinical characteristics, radiological features, and surgical
prognosis.
Materials and Methods: A retrospective review was carried out to
investigate the patients with adultWilms' tumor at the Tri-Service General
Hospital during a 45-year period (1970 - 2014). Seven patientsS 16 years
old (one female and six male; median age at the time of diagnosis of 24
years; range 24 - 48 years) were staged according to the National Wilms'
Tumor Study (NWTS) staging system as follows: 3 patients had stage II
disease, 2 patients had stage III disease and 2 patients had stage IV disease
Results: The most common presentation is ﬂank pain (57%) followed by
palpable mass (43 %). Only one patient presented with gross hematuria.
Four patients underwent renal arteriography which all disclosed irregular,
tortuous vessel pattern with faint tumor stain. All patients underwent
radical nephrectomy (one hand-assisted laparoscopic nephrectomy and 6
open transperitoneal nephrectomy). Two patients developed lung metas-
tases after radical surgery. All but one patient received multimodal ther-
apy, including surgery, chemotherapy and radiation therapy. The mean
disease-free survival is 81months. Three-year and ﬁve-year survival rate is
60 % and 50 % separately.
Conclusion: Selective renal arteriography provides valuable diagnostic
hint in adult Wilms' tumor. Using multimodality therapy, improved
prognosis could be achieved.
NDP081:
EFFICACY OF SWITCHING THERAPY OF LUTEINIZING HORMONE-
RELEASING HORMONE ANALOGUE FOR ADVANCED PROSTATE CANCER
Yuan-Chi Shen, Chih- Hsiung Kang, Po-Hui Chiang. Department of Urology,
Kaohsiung Chang Gung Memorial Hospital, Taiwan
Purpose: To determine the efﬁcacy of switching therapy with a second
LHRH analogue after PSA progression for advanced prostate cancer.
Materials and Methods: Between December 2005 to September 2013,
there were 200 patients with nodal positive, metastatic prostate cancer
or disease progression after deﬁnite treatment receiving continuous
LHRH analogues therapy with monthly Depot leuprorelin (sc)
acetate 3.75mg/vial (LA) or Gorserelin acetate (sc) 3.6mg /vial (GA). If
the patients had castration resistant prostate cancer, the treatment
choice of switching therapy (LA to GA or GA to LA) before entering
chemotherapy was given.The LH, testosterone level and PSA change
were recorded.
Results: 127 patients receiving LA as initial ADT therapy and the other
73 patients were in GA therapy. A total of 92 patients (54 patients got
LA to GA and 38 got GA to LA) got LHRH analogue switching therapy.
The effect of LH and testosterone reducing before and after switching
therapy was comparable between two groups and the increasing PSA
level after three-months treatment was seen in both groups (median
PSA: 15.7 to 67.7ng/ml in LA to GA group and 15.2 to 71.4ng/ml in GA to
LA group).
Conclusion: Switching therapy for patients with PSA progression after
ADT has no efﬁcacy of further PSA decrease.
NDP082:
FUNCTIONAL OUTCOME PREDICTION AFTER PARTIAL NEPHRECTOMY
USING R.E.N.A.L NEPHROMETRY, PADUA CLASSIFICATION AND
CENTRALITY INDEX SCORE
Ding-Po Lin, Huang-Kuang Chang, Stone Yang, Jong-Ming Hsu, Yung-
Chiong Chow, Wei-Kung Tsai, Pai-Kai Chiang, Marcelo Chen, Chih-Chiao
Lee, Wun-Rong Lin. Department of Urology, Mackay Memorial Hospital,
Taipei, Taiwan
Purpose: Several scoring system have been proposed to quantify surgical
complexity, and provide insight into expected perioperative and post-
operative surgical outcomes following partial nephrectomy. However, it is
still unclear that which of the scoring system has better outcome in pre-
dicting functional outcome after partial nephrectomy. In the present
study, we assess the use of R.E.N.A.L., PADUA and centrality index scores
to predict the renal function for patients who underwent partial
nephrectomy.
Abstracts / Urological Science 26 (2015) S50eS81 S71Materials and Methods: We retrospectively reviewed 26 cases with renal
tumors managed by open partial nephrectomy at our institution from
January 2008 to October 2013. R.E.N.A.L., PADUA and centrality index
scores were assigned according to the described protocols for those sys-
tems. We evaluated the association between scoring systems and both
early and late postoperative functional outcome.
Results: The mean age of study population was 56 years old. Of the pa-
tients 18 (69%) were male. Mean tumor size was 4.04cm. Each scoring
system performed signiﬁcant correlation with both early and late func-
tional outcome (p < 0.05), whereas R.E.N.A.L nephrometry and PADUA
classiﬁcation showed high correlation (-0.715 and -0.721) and centrality
index showed moderate correlation (0.451). Single anatomical parameter
as diameter of tumor does not correlate with functional outcome signiﬁ-
cantly. (p ¼ 0.974 in one day after surgery and p ¼ 0.865 in one year after
surgery).
Conclusion: R.E.N.A.L., PADUA and centrality index scores were inversely
associated with renal function preservation after partial nephrectomy. In
this regard it is possible to use theses scoring systems preoperatively to
gauge the magnitude of functional decrease.
NDP083:
PROSTATE DUCTAL ADENOCARCINOMA e CLINICAL EXPERIENCES IN
TAIPEI VETERANS GENERAL HOSPITAL
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Huang 1,2,3, Howard H.H. Wu 1,2,3, Yen-Hwa Chang 1,2,3, Alex T.L.
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Medicine, Taiwan; 3 Shu-Tien Urological Science Research Center, National
Yang-Ming University, Taiwan
Purpose: Ductal adenocarcinoma of the prostate is a rare histological
subtype of primary prostate cancer. Previous reports had showed that
ductal adenocarcinoma of the prostate had a distinct behavior when
compared to common acinar adenocarcinoma. About prostate acinar
adenocarcinoma, previous studies had showed different incidence, risk,
and prognostic condition, but due to the rarity of prostate ductal adeno-
carcinoma, the reports of prostate ductal adenocarcinoma in Asian popu-
lation are still limited in small case series/reports. We intended to share
our experiences and analyzed the treatment outcome.
Materials and Methods: Patients with diagnosis of prostate ductal
adenocarcinoma in our hospital during 2001~2014 were retrospectively
reviewed. The initial symptoms, PSA level, treatment, and follow-up con-
dition were retrieved for analysis.
Results: 18 patients had been diagnosed with prostate ductal adenocar-
cinoma during the period. Themean age of presentationwas 75.5 years old
(62-85). The most presenting symptoms is LUTS with elevated PSA. The
median initial PSA level was 21.67ng/ml (2.47-629). The mean follow-up
time was 29.1 months (2-126). 5 patients had radiographic distant
metastasis or invasion to adjacent organ at initial staging. 12 patients were
diagnosed by transrectal sonography-guided prostate biopsy; 2 patients
were diagnosed by transurethral resection of prostate, 1 patient was
diagnosed by transurethral resection of bladder tumor, and 3 patients
received radical prostatectomy due to localized disease. Among these 3
patients, 2 patients were current disease-free with 14, 24 month follow-
up. Another patient presented with bone metastasis 20 months after RRP
and died of the disease 34 months after the operation despite hormone
therapy. Totally only 5 patients had survived at least 3 years.
Conclusion: Ductal prostate adenocarcinoma tends to present with
advanced clinical stage, relatively lower PSA levels then common prostate
acinar carcinoma and the clinical behavior seems more aggressive. Clini-
cally, we should regard these patients as a distinct group, which different
from common prostate acinar adenocarcinoma patients.
NDP084:
ASSOCIATION OF POLYMORPHISMS IN INOS AND NQO1WITH BLADDER
CANCER RISK IN CIGARETTE SMOKERS
Zhon-Min Huang 1, Min-Che Tung 1, Yi-Te Chiang 2, Cheng-Huang
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Taiwan; 4Department of Urology, Shin-Kong Wu Ho-Su Memorial Hospital,
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Purpose: NAD(P)H:quinine oxidoreductase (NQO1) plays an important
role in the metabolism of several carcinogens contained in cigarettes.
Inducible nitric oxide synthase (iNOS) expression had been detected in
urinary bladder tumors. The aim of this study was to investigate the
interaction of iNOS and NQO1 on bladder cancer (BC) risk stratiﬁed by
cigarette smoking status.
Materials and Methods: A total of 159 BC patients and 150 cancer-free
controls were recruited from December 2003 to November 2004.
Genotyping of NQO1 rs1800566 polymorphism and iNOS (CCTTT)n
pentanucleotide repeat polymorphism was determined using the
polymerase chain reaction-restricted fragment length polymorphism
and sequencing method. The odds ratio and 95% conﬁdence interval
(CI) were calculated as a measure of the joint effect of NQO1 rs1800566
and iNOS (CCTTT)n polymorphisms on BC risk among cigarette
smokers.
Results: Compared with study participants carrying the C/C genotype of
NQO1 gene, those with C/T and T/T genotypes had a signiﬁcantly
increased BC risk of 1.8 (95% CI ¼ 1.1-2.9). Among cigarette smokers,
those who carried the 12-repeat allele of iNOS (CCTTT)n polymorphism
had a signiﬁcantly increased BC risk of 2.7 (95% CI ¼ 1.0-6.7). Further-
more, a signiﬁcant combined effect of the C/T and T/T genotypes of
NQO1gene and the 12-repeat allele of iNOS (CCTTT)n repeat poly-
morphism on BC was found among cigarette smokers (odds ratio ¼ 4.4,
95% CI ¼ 1.3-14.9).
Conclusion: Our ﬁndings suggest that a signiﬁcant combined effect of
NQO1 C/T and T/T genotypes and the 12-repeat allele of iNOS (CCTTT)n
polymorphism on BC exists, especially in those with the habit of cigarette
smoking.
NDP085:
IMPACT OF INTERLEUKIN-18 POLYMORPHISMS ON UROTHELIAL CELL
CARCINOMA SUSCEPTIBILITY IN TAIWAN
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Purpose: Interleukin-18 (IL-18) is an 18-kDa cytokine and has similar
structural and functional properties with interleukin-1. IL-18 is produced
by various immune and non-immune cells and serum IL-18 level is re-
ported to have prognostic signiﬁcance in several types of cancers. We
explored the effect of IL-18 gene polymorphisms on the susceptibility of
urothelial cell carcinoma (UCC) in Taiwan.
Materials and Methods: We recruited 283 patients (186 men and 97
women, with a mean age of 68.59 years) at Taichung Veterans General
Hospital in Taichung, Taiwan. Patients were enrolled as a patient group in
2011e2012. All patients have pathology proved UCC of upper urinary
tract or urinary bladder. Meanwhile, during the same study period, 283
age- and gender-matched individuals were enrolled as the controls that
entered the physical examination. Personal information and character-
istics collected from the study subjects using interviewer administered
questionnaires contained questions involving demographic characteris-
tics and the status of cigarette smoking. Medical information for the
cases was obtained from their medical records, and included TNM clin-
ical staging, lymph node involvement, and histologic grade.Allelic
discrimination of -607A/C (rs1946518) and -137G/C (rs187238) poly-
morphisms of the IL-18 gene was assessed by a real-time PCR with the
TaqMan assay.
Results: After adjusting for other co-variants, the individuals carrying at
least one C allele at rs187238 had a 1.617-fold risk of developing UCC than
did wild-type (GG) carriers. Furthermore, the smoking individuals who
